U.S. Medical Equipment Stock News

Constellation Energy stock jumped about 3.4% to roughly US$270 after earnings, which suggests sentiment is leaning bullish. The question for investors is whether that move fits the story in the numbers. The company delivered Q2 basic earnings per share of US$1.43 on revenue of US$7.5b and lifted full-year adjusted operating earnings guidance to a range of US$11.50 to US$12.50 per share. For a power producer that depends heavily on contracted cash flows and nuclear fleet reliability, that...

Starwood Property Trust stock jumped 3.3% to US$16.45 as investors cheered a headline that sits squarely in the balance sheet risk column rather than the growth column. The market appears to be rewarding a cleaner path through troubled commercial real estate, even though the quarter’s story is really about how much capital is still tied up in problem loans and real estate owned. The key tension is simple. Distributable earnings of US$0.40 per share and undepreciated book value of US$18.62...

Weave Communications stock just dropped 20% to close at US$5.29, even though the quarter that triggered the selloff looked very different from a simple disappointment story. The company posted Q2 2026 revenue of US$67.5m and reported positive operating income of US$3.2m, a rare profit milestone for a software platform that still reports losses on a net basis. The short term mood is clearly risk off. The longer term question is whether this first taste of operating profitability and solid top...

Synaptics jumped about 4% today, yet the stock is still down double digits over the past month. That clash between a relief rally and a weak short-term tape sets the stage for earnings that are all about one thing: the strain on profitability. The company just posted quarterly revenue of US$308 million, but the headline is the deep net loss for the year and sharply negative trailing twelve month earnings from continuing operations of US$490.8 million. For a semiconductor stock that trades on...

Dauch Corporation recently reported past second-quarter 2026 results showing sales rising to US$2,955.6 million from US$1,536.2 million a year earlier, while net income fell to US$1 million from US$39.3 million. Over the first half of 2026, sales climbed to US$5,334.5 million from US$2,947.5 million, yet the company moved from a US$46.4 million net profit to a US$99.3 million net loss, highlighting pressure on profitability despite strong top-line growth. We will now examine how this...

Karman Holdings stock jumped 5.6% to US$58.23 after earnings, even though the shares had been roughly flat over the past week and slightly weaker over the past quarter. The pop reflects a simple headline: Karman just put up record Q2 revenue of US$182 million and doubled quarterly net income to US$14 million compared with early 2025 levels. That is the short term story. The longer term question for you is whether this pace of growth and rising earnings justifies a stock that trades on a rich...

Groupon stock barely flinched after earnings, slipping less than 1% to about US$25, even as the core story shifted in a more complicated way. On the surface you saw a coupon-era relic with another quarterly loss and billings and revenue roughly flat. Underneath, you had adjusted earnings before interest, tax, depreciation and amortization at the top of guidance and free cash flow of US$15 million that pointed to a business attempting to trade headline revenue softness for cleaner cash...

iRhythm Holdings stock barely flinched after earnings, slipping just 0.2% to about US$127. That muted move sits awkwardly next to a quarter that effectively erased the company’s losses and pushed free cash flow firmly into positive territory. This is a classic sentiment mismatch, where a cardiology technology business posts record adjusted profitability while the share price trades as if very little has changed. The real headline is simple. iRhythm just paired roughly US$224.2m in revenue...

Nova stock came into this earnings print on the back foot, down 24.6% over the past three months. The market snapped back fast with a 3.1% jump to about $393 after the release. The headline is simple. Record Q2 revenue of about $255m and basic earnings per share of $2.36 reinforced the idea that Nova is still converting the current chip upcycle into solid profit. For a company often viewed through a rich valuation lens, that combination of top line strength and firm profitability is what...

ProFrac Holding stock slipped about 3% to US$4.32 after the Q2 print, even though the numbers told a more nuanced story. Revenue landed at US$498.1 million and adjusted earnings before interest, tax, depreciation and amortization improved to US$69 million with a 14% margin. For a pressure pumping and proppant supplier that has been wrestling with losses and a thin liquidity buffer, that margin progress is the headline. The near term still looks messy, but the real question for you is whether...

BXP stock came into this earnings print with a solid 90 day run and then added another 1.3% in the latest session. The move is modest compared with the story inside the numbers. The headline is funds from operations. BXP posted Q2 funds from operations of US$283.4 million, with funds from operations per share of US$1.78, ahead of its earlier guidance and enough for management to lift full year funds from operations guidance. For an office real estate investment trust, that guidance raise, not...

Arlo Technologies went into this earnings print on a strong short term run, with the stock up about 19% over the past month, yet shares slipped 1.6% to about US$15.23 once the numbers hit. That gap captures the real headline for you. The smart home security company put up a record quarter on revenue and profitability, but the clean story is tempered by tariff refunds that gave earnings per share and product margins an extra boost. For investors, the question now is how much of this quarter’s...

Onity Group stock jumped 6.7% to US$39.39 after earnings, which indicates traders liked the headline. The catch is that the quarter delivered a GAAP net loss on roughly US$283 million of revenue, driven by one-time transaction costs and swings in mortgage servicing rights values. As a result, the stock re-rated higher on the day while the income statement highlighted how sharp the earnings swings can be. The real story for long-term holders is not today’s price move. It is whether this latest...

Distribution Solutions Group spent the past month in a quiet rerating, with the stock up close to 30%, yet the immediate reaction to fresh Q2 numbers is a flat line. A 0.2% move on the day suggests investors are unsure whether to trust the earnings rebound or to worry about the quality of that recovery. The headline is simple: Revenue reached about US$557.7m and basic earnings per share came in at US$0.18, while interest costs still press on the story. The market is treating this as business...

Starling Oncology jumped 28% to US$6.41 after its Q2 release, a sharp repricing for a stock that had already logged strong double digit gains over the past quarter. The headline is not earnings per share; the swing factor is cash and profitability. Starling Oncology booked its second profitable quarter on an adjusted EBITDA basis and reported positive free cash flow alongside US$41.1m of cash and a fresh term loan that pushed major debt maturities out to 2031. The market moved on the day. The...

Ralph Lauren stock barely flinched after earnings, slipping just 0.1% to about US$395 even as the quarter landed with the force of a well aimed price reset. This is a brand often viewed as a steady compounder, yet the latest numbers leaned far more on profit power than on quiet stability. The headline is margin strength. Adjusted gross margin reached 73.6% and adjusted operating margin came in at 18.5%, both supported by a 15% jump in average unit retail. The stock came into the print already...

TE Connectivity stock has delivered a 70.7% return over the past three years, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach still suggest the shares trade at a discount to what the underlying cash flows imply. A 70.7% return over three years points to a stock the market has rewarded, which makes any remaining valuation gap more important to scrutinize carefully. For TE Connectivity, expectations around the durability of its cash...

Warby Parker stock slipped about 1.9% today to US$26.46, extending a weaker run over the past three months, yet the latest quarter told a different story. The Q2 headline was profitability holding and earnings ticking higher, even as revenue came in at US$235.5m. Adjusted EBITDA of US$32.9m, helped by a one time tariff refund, gave the company more room to invest ahead of its Intelligent Eyewear push. For short term traders, the modest price drop will stand out. For longer term investors, the...

Keurig Dr Pepper stock slipped about 1% to US$30.01 after the Q2 earnings hit the tape, a muted reaction for a quarter that radically reshaped the story. The market seems more focused on a soft recent share price trend than on what just landed in the income statement. The real headline is profit pressure. Quarterly basic earnings per share came in at about US$0.04 on net income of US$60m against revenue of US$7.3b. That mix of heavy top line and light profit sits within a richer P/E and a...

Immunocore Holdings slipped 1.45% to US$34 after earnings, a modest move for a biotech that reported another quarter of solid product revenue and a near breakeven bottom line. The stock had quietly gained over the past three months, so today’s reaction appears more like a pause than a verdict. The key point is that KIMMTRAK helped drive Q2 revenue to US$115.9m while the company reported a net loss of only US$0.8m. For a high research and development oncology platform, that shrinking loss...

A surprise loss of 23,000 jobs in July and weaker past hiring have put the labour market under fresh scrutiny. Slower growth can shift expectations for interest rates, which often steers money toward sectors seen as more resilient. Healthcare stocks sit firmly in that conversation. This article walks through three larger healthcare companies from our screener that appear well positioned or vulnerable to these cross currents, so you can decide how they might fit your watchlist. The stocks in...

EPAM Systems stock jumped 4.7% to about US$97 in the first full session after earnings, a sharp move for a company that had been treading water over the past week. The headline was clear enough for the market. Q2 revenue came in around US$1.4b and non GAAP earnings per share reached US$3.38, helped by a non GAAP operating margin of 16.4%. Short term traders focused on that margin snapback. Long term holders will be weighing the slower full year revenue outlook against EPAM Systems’ push into...

The market clipped Citizens Financial Services by about 2.3% today, even though the earnings story looked steadier than the share price reaction suggests. Heading into the release, the stock had quietly added double digit returns over the past month and quarter, helped by a P/E of 9.4x that sits below both US banks and close peers. The headline this quarter is not revenue or earnings per share. It is credit quality. Non performing loans increased to just over US$41 million while the allowance...

Talkspace stock barely moved after earnings, ticking up just 0.2% to US$5.22. The quiet price action hides a more complicated picture. The online therapy provider is still posting quarterly losses, with Q2 basic earnings per share at roughly a US$0.01 loss and net income in the red. At the same time, the trailing twelve month figures show Talkspace hovering around break even profit and carrying a richer price to sales ratio than many healthcare peers. The key issue for investors is whether...